Skip to content

Main Navigation

Clinical Study

Janssen COVID-19 Vaccine Study

This Phase 3 clinical study will assess the effectiveness of a novel COVID-19 vaccine. It includes a placebo such that half the participants will receive active COVID vaccine and half will receive placebo. Study participants will provide written informed consent, then they will be vaccinated and followed for one year.


For more information contact:

MaryJane Tinnes

IRB#: IRB_00135837 | PI: John Kriesel | Department: INTERNAL MEDICINE | Approval Date: 2020-10-28 06:00:00
Study Categories: COVID-19 Studies | Specialties: Infectious Diseases

Who can participate?

 Gender: All

 Age: Over 18 years old

 Volunteers: Healthy Volunteers

 Location: In Person

 COVID-19 Study

Will I be paid for my time?


Last Updated: 4/5/21